We have located links that may give you full text access.
Journal Article
Research Support, U.S. Gov't, P.H.S.
Arginine vasopressin receptor internalization and recycling in rat renal collecting tubules.
Journal of Receptor Research 1994 Februrary
Arginine vasopressin (AVP) binds to two distinct receptors to initiate vasopressor (V1 receptor) and hydroosmotic actions (V2 receptor). Internalization and recycling of the V1 receptor in cultured vascular smooth muscle cells and hepatocytes have recently been demonstrated. However, the receptor cycle of the AVP V2 receptor in the renal collecting tubules has not yet been well defined. Therefore, the present study was undertaken to investigate the AVP V2 receptor cycle, including AVP binding to the surface receptor, internalization and potential recycling in isolated outer medullary collecting tubules. The maximal AVP surface binding was reached in 10 min, and 25 micrograms/ml trypsin completely inhibited the surface binding. A Scatchard plot of 125I-AVP surface binding indicated a single population of V2 receptors with a Kd of 1.92 x 10(-9) M and a Bmax of 1.77 x 10(-11) M or 590 fmoles/mg protein. 81.7% (72-85%) of specific bound receptor was internalized (specific surface binding: 742.8 +/- 111.1 vs internalized binding: 607.3 +/- 27.8 fmoles bound/mg protein). More than 90% of surface bound receptor was recycled to the cell surface after internalization (control surface binding: 584.0 +/- 64.0 vs recycled surface binding: 546.6 +/- 32.0 fmoles bound/mg protein). Cycloheximide (40 micrograms/ml) did not inhibit the receptor recycling (control recycled surface binding: 546.6 +/- 32.0 vs cycloheximide recycled surface binding: 505.0 +/- 54.8 fmoles bound/mg protein), thus suggesting that the receptors were not resynthesized after dissociation from the receptor-ligand complex. These studies therefore demonstrate that the AVP V2 receptor is internalized and recycled in the rat renal collecting tubule.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app